Alkermes
Alkermes bolts on Rodin Therapeutics to bulk up thin pipeline
Phil Taylor
Alkermes, Alzheimer's disease, dementia, M&A, neurology
0 Comment
X
Alkermes bolts on Rodin Therapeutics to bulk up thin pipeline
https://pharmaphorum.com/news/alkermes-bolts-on-rodin-therapeutics-to-bulk-up-thin-pipeline/
X
Alkermes rebuffed by FDA on antidepressant
https://pharmaphorum.com/news/alkermes-rebuffed-by-fda-on-antidepressant/
Alkermes/Biogen hope for less tummy trouble with new MS pill
Richard Staines
Alkermes, Biogen, multiple sclerosis, R&D
0 Comment
X
Alkermes/Biogen hope for less tummy trouble with new MS pill
https://pharmaphorum.com/news/alkermes-biogen-hope-for-less-tummy-trouble-with-new-ms-pill/
X
Alkermes preps filing for weight-friendly schizophrenia drug
https://pharmaphorum.com/news/alkermes-preps-filing-for-weight-friendly-schizophrenia-drug/
X
FDA panel backs Sage’s novel antidepressant but turns down Alkermes’
https://pharmaphorum.com/news/fda-panel-backs-sages-novel-antidepressant-but-turns-down-alkermes/
Alkermes closing in on Biogen with MS rival
Richard Staines
Alkermes, Biogen, gastrointestinal, multiple sclerosis
0 Comment
ALKS 8700 may have fewer side effects than Tecfidera.
X
Alkermes closing in on Biogen with MS rival
https://pharmaphorum.com/news/alkermes-closing-biogen-ms-challenger/